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SPECIFIC AIMS
Alzheimer's disease (AD) is characterized by excessive
deposition of aggregated -amyloid (A) peptide of
40-42 residue, which is derived from the amyloid pre-
cursor protein (APP) following processing by -secre-
tase and -secretase. We have reported that develop-
mental exposure to Pb up-regulates the expression
levels of APP and its amyloidogenic A products late in
life. This provided the first evidence for the develop-
mental and environmental link for disturbances in
AD-associated proteins. Our aim was to examine
whether latent up-regulation in APP expression and A
levels are exacerbated by concurrent disturbances in
APP processing or A aggregation.
PRINCIPAL FINDINGS
1. Nanomolar levels of Pb promote A aggregation
Increased APP expression and/or processing are be-
lieved to accelerate AD pathogenesis in humans and
animal models of AD due to the increased production
of the amyloidogenic peptides A1-40 and A1-42. Envi-
ronmental agents could exacerbate such a situation by
directly promoting A aggregation; therefore, we de-
cided to examine the effects of xenobiotic metals on
human A aggregation in vitro.
The fluorescent dye 1,1-bis(anilino)napthaline-5,5-
disulfonic acid (bis-ANS) was used to probe the confor-
mational properties of A and A aggregates in the
absence and presence of metals at various concentra-
tions. Bis-ANS is known to bind aggregated but not
monomeric A. The non-amyloidogenic A 40-1 was
used as a control in these experiments. Among the
environmental metals tested, only A solutions contain-
ing Pb were observed to bind tightly to bis-ANS, consis-
tent with the presence of A aggregates. The aggrega-
1 Correspondence: Department of Biomedical and Pharma-
ceutical Sciences, University of Rhode Island, Kingston, RI
02881, USA. E-mail.nzawia@uri.edu
Figure 1. Fluorimetric detection of A1-40 aggregation and its
reverse sequence peptide A40-1 (control) using bis-ANS. a)
A1-40 samples were prepared for the fluorescence studies
and the emission spectra was recorded at 455–550 nm. The
intensity of fluorescence was used as a measure of aggrega-
tion. Values shown are the mean  se (n4). *Significantly
different from control (P0.05) as determined by ANOVA
and Duncan’s post hoc test. b) Affinity of bis-ANS to bind
A1-40 and A40-1 (control peptide).
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tion patterns observed using this method were dose
dependent.
2. Developmental exposure to Pb has no latent effect
on activity of secretase enzymes
We have previously shown that exposure to Pb during
development up-regulates APP expression. Here we
wanted to determine whether APP processing by secre-
tases was also affected by developmental events. We
profiled the cortical activity levels of -, -, and -secre-
tases across the life span of rodents. We found that the
activities of -, -, and -secretases peaked during early
brain development, decreased to basal levels in adult-
hood, and remained constant for the rest of the ani-
mals’ lives. We examined the effects of Pb exposure on
the activity of each secretase using cortical tissue from
three different groups: control, Pb-E (exposed to 200
ppm Pb in drinking water from birth to weaning), and
Pb-L (exposed to 200 ppm Pb in drinking water from
18 to 20 months). We found that there were no
significant changes in the activity levels of any of the
three enzymes among these groups at 20 months of age
(Fig. 2).
CONCLUSIONS
AD is a progressive neurodegenerative disorder whose
clinical manifestations appear in old age. Most theories
and mechanisms proposed to explain the pathogenesis
of sporadic AD focus on events or disturbances that
occur during old age. The long latency of AD suggests
that this neurodegenerative disease remains asymptom-
atic for decades before a progressive accumulation of
damage becomes clinically detectable. Our findings
suggest that the initial events which trigger this disease
begin very early in life and may be worsened by re-
exposure to environmental agents late in life. Therefore,
we propose that amyloidogenesis is promoted by a latent
response to developmental reprogramming of the expres-
sion of the APP gene by early exposure to Pb as well as
enhancement of A aggregation in old age. In rodents,
these events occur without Pb-induced disturbances to the
enzymatic processing of APP. The findings described
above provide further evidence for the developmental
basis of amyloidogenesis and late life disturbances in
AD-associated proteins by environmental agents.
Figure 2. Effect of developmental and aging exposure to Pb
on the activity levels of -, -, and -secretases in the cortex:
Animals were exposed to 200 ppm Pb-acetate (Pb-E: birth
through weaning; Pb-L: 18–20 months of age). Brain cortices
were obtained from 20-month-old control, Pb-E, and Pb-L
animals. Cell lysates were prepared from these tissues and
analyzed for the activity levels of -, -, and -secretases using
the R&D Systems kit. The intensity of fluorescence was used
as a measure of enzyme activity. Each data point represents
the mean  se (n4–6). Blood and tissue levels of Pb are
shown in the insert. *Significantly different from their corre-
sponding controls (P0.05).
Figure 3. Schematic diagram showing the possible sites of
action for Pb () in the amyloidogenesis pathway: Rodent
studies show that developmental exposure to Pb results in a
latent effect on the expression of APP via the transcriptional
mechanisms. This overexpression of the APP gene leads to an
over production of the APP and its amyloidogenic product
A, thereby causing neurodegeneration and plaques forma-
tion in the brain. In vitro studies using a synthetic A peptide
suggest that Pb can promote the aggregation of A. Items
marked with an arrow (1) show an elevation in intermediates
in the pathway due to Pb exposure.
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